Inactive Ingredient Search for Approved Drug Products

About this Database | Back to Search Page

Guidances | CFR

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with W

	Quarter	Inactive Ingredient	Route of Administration	Dosage Form	Maximum Potency per unit dose	Maximum Daily Exposure	Status
138547	Q2 2022	WHITE WAX	ORAL	CAPSULE, EXTENDED RELEASE	15.30 mg		MDE Replacement
138548	Q3 2022	WHITE WAX	ORAL	CAPSULE, EXTENDED RELEASE		71mg	MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 1, 2022
Database Last Updated: July 18, 2022